UBS Group’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.4K Buy
+1,326
New +$38.6K ﹤0.01% 7537
2025
Q4
Sell
-51
Closed -$1.24K 10817
2025
Q3
$1.24K Buy
+51
New +$1.17K ﹤0.01% 9399
2025
Q2
Sell
-145
Closed -$3.07K 10517
2025
Q1
$3.07K Buy
+145
New +$3.22K ﹤0.01% 9252
2024
Q4
Sell
-348
Closed -$8.28K 10136
2024
Q3
$8.28K Buy
+348
New +$8.31K ﹤0.01% 7846
2023
Q4
Sell
-205
Closed -$4.06K 9566
2023
Q3
$4.06K Sell
205
-1,619
-89% -$33K ﹤0.01% 7479
2023
Q2
$37.3K Buy
+1,824
New +$38.2K ﹤0.01% 6622
2023
Q1
Sell
-450
Closed -$9.49K 9928
2022
Q4
$9.49K Buy
+450
New +$9.31K ﹤0.01% 8647
2022
Q3
Sell
-170
Closed -$3K 10595
2022
Q2
$3K Sell
170
-1,084
-86% -$20.7K ﹤0.01% 9321
2022
Q1
$26K Buy
1,254
+905
+259% +$18.8K ﹤0.01% 7142
2021
Q4
$8K Buy
+349
New +$8.51K ﹤0.01% 9036

Other funds holding IBBQ

UBS Group's IBBQ Position: Q1 2026 in Review

UBS Group opened a new position in Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2026: 1,326 shares worth $38.4K. The stake represents ﹤0.01% of the portfolio and ranks #7537 among its holdings. This is a return to the name: UBS Group previously reported a position in IBBQ as recently as Q3 2025.

UBS Group first reported a position in IBBQ in Q4 2021 and has held it in 10 quarters since. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • UBS Group held 1,326 shares of Invesco NASDAQ Biotechnology ETF worth $38.4K as of Q1 2026.
  • Invesco NASDAQ Biotechnology ETF was a new UBS Group position in Q1 2026.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7537 holding.
  • UBS Group first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2021 and has held it in 10 quarters since.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.